Show an ad over header. AMP

Big Pharma, policymakers, philanthropies and development banks launch $1 billion venture

A group of large drug companies launched a $1 billion AMR Action Fund Thursday in collaboration with policymakers, philanthropists and development banks to push the development of two to four new antibiotics by 2030.

Why it matters: Antimicrobial resistance (AMR) is a growing problem — possibly killing up to 20 million people annually by 2050 — but a severe lack of R&D market incentives has hampered efforts to develop a robust antibiotic pipeline to address the issue.


"Antimicrobial resistance, I do believe, is the existential threat of this century."
Admiral Brett P. Giroir, assistant secretary for health, said at a Thursday press conference

What's happening: AMR problems have been growing for decades, as bacteria, viruses, fungi and parasites become resistant to medicines and sometimes to multiple medicines.

  • Giroir, who practiced pediatric care for 14 years, said "literally not a day went by that I did not have a child, struggling for survival, in a life-and-death battle with a resistant organism."
  • "AMR is like the COVID-19 pandemic — [but happening] nearly every year. Statistics show us that AMR killed 700,000 people globally in just the last year. And, by 2050 could kill as many as 20 million annually," Eli Lilly CEO David Ricks says.
  • Giroir says in the U.S. there are more than 2.8 million AMR infections with 35,000 deaths every year.
  • "Going forward, the capacity to develop antibiotics to infectious agents, I think, is going to be seen as a matter of national security," says Scott Gottlieb, resident fellow at the American Enterprise Institute and former FDA commissioner.

The problem: It's expensive to develop a new antibiotic without being able to have a consistent market to provide a return on investment, drug executives said, particularly as effective novel antibiotics tend to be stored to address rising AMR problems in the future, rather than being distributed.

  • "We're asking folks to develop drugs but we're asking doctors not to prescribe them," says GOP Sen. Bill Cassidy, who adds it's a necessary paradigm that needs properly functioning market incentives.
  • The current COVID-19 pandemic — in which many patients experience secondary infections that are sometimes antibiotic-resistant and deadly — is a reminder of the need for new antibiotics, the participants in the press conference said.
  • "Unless the U.S. government changes antibiotic reimbursement, today's excitement will end in bankruptcy. Big companies have exited antibiotics for very good reason — bad economics," CARB-X executive director Kevin Outterson points out.
  • Recent legislative efforts are attempting to address the problem, including the DISARM Act in both the House and the Senate, according to Sen. Bob Casey.

How it works: The fund is a roughly $1 billion venture consisting of more than 20 pharmaceutical companies, philanthropies, development banks and multilateral organizations, says PhRMA president Steve Ubl.

  • The focus will be on small and middle sized enterprises that lack access to capital, Ricks says.
  • Beyond funding, the AMR Action Fund will also provide technical support to small biotech portfolio companies, Merck CEO Ken Frazier says. Sustained investment is needed as it often takes 12 to 15 years to develop new drugs, he adds.
  • The World Health Organization and the European Investment Bank, amongst other organizations, will provide assistance.
  • The fund will extend efforts currently led by CARB-X, a public-private enterprise that invests in significant research in companies working on the early phase of developing new antibiotics. "The timing of this AMR Action Fund is life-saving for these research companies and life-saving to the world," Outterson says.

The bottom line: "The next pandemic may be a superbug," Cassidy says. "We are preparing now for this next pandemic. And there will be people alive, because of this development, [who] otherwise would not be alive."

Go deeper:

Boris Johnson announces month-long COVID-19 lockdown in U.K.

U.K. Prime Minister Boris Johnson on Saturday outlined his plan for the country's second coronavirus lockdown as the nation topped the 1 million case mark, per Johns Hopkins University data.

Details: Starting Thursday, people in England must stay at home, and bars and restaurants will close except for takeout. All non-essential retail will also be shuttered. Inter-mingling between households and outbound international travel or out-of-home boarding will be prohibited. The new measures will last through at least December 2.

Keep reading... Show less

Trump's legacy is shaped by his narrow interests

President Trump's policy legacy is as much defined by what he's ignored as by what he's involved himself in.

The big picture: Over the past four years, Trump has interested himself in only a slim slice of the government he leads. Outside of trade, immigration, a personal war against the "Deep State" and the hot foreign policy issue of the moment, Trump has left many of his Cabinet secretaries to work without interruption, let alone direction.

Keep reading... Show less

Ipsos poll: COVID trick-or-treat

Data: Axios/Ipsos poll; Note ±3.3% margin of error for the total sample size; Chart: Andrew Witherspoon/Axios

About half of Americans are worried that trick-or-treating will spread coronavirus in their communities, according to this week's installment of the Axios/Ipsos Coronavirus Index.

Why it matters: This may seem like more evidence that the pandemic is curbing our nation's cherished pastimes. But a closer look reveals something more nuanced about Americans' increased acceptance for risk around activities in which they want to participate.

Keep reading... Show less

Dunkin' Brands agrees to $11B Inspire Brands sale

Dunkin' Brands, operator of both Dunkin' Donuts and Baskin-Robbins, agreed on Friday to be taken private for nearly $11.3 billion, including debt, by Inspire Brands, a quick-serve restaurant platform sponsored by Roark Capital.

Why it matters: Buying Dunkin’ will more than double Inspire’s footprint, making it one of the biggest restaurant deals in the past 10 years. This could ultimately set up an IPO for Inspire, which already owns Arby's, Jimmy John's and Buffalo Wild Wings.

Keep reading... Show less

Federal judge halts Trump administration limit on TikTok

A federal judge on Friday issued an injunction preventing the Trump administration from imposing limits on the distribution of TikTok, Bloomberg reports. The injunction request came as part of a suit brought by creators who make a living on the video service.

Why it matters: The administration has been seeking to force a sale of, or block, the Chinese-owned service. It also moved to ban the service from operating in the U.S. as of Nov. 12, a move which was put on hold by Friday's injunction.

Keep reading... Show less

Podcast: How hospitals are prepping for the new COVID-19 surge

Coronavirus cases and hospitalizations are surging, particularly in areas that had been largely spared in the spring. One big question now is if hospitals are better prepared for this new wave, including if they'll be able to continue providing elective services.

Axios Re:Cap digs into what hospitals have, and what they still need, with Lloyd Dean, CEO of CommonSpirit Health, one of America's largest operators of hospitals and health clinics.

Belgium imposes lockdown, citing "health emergency" due to influx of COVID-19 cases

Belgium is enforcing a strict lockdown starting Sunday amid rising coronavirus infections, hospital admissions and a surge of deaths, Prime Minister Alexander De Croo announced on Friday.

Why it matters: De Croo said the government saw no choice but to lock down "to ensure that our health care system does not collapse." Scientists and health officials said deaths have doubled every six days, per the Guardian.

Keep reading... Show less

First look: Reid Hoffman launches $1M ad urging election patience

Billionaire and LinkedIn co-founder Reid Hoffman, one of Democrats' biggest donors, tells Axios he's launching a $1 milliondigital ad campaign in battleground states urging voters to be patient with election results and prepare for no winner to be known on Nov. 3, no matter what "some people" may prematurely declare via Twitter.

Driving the news: The three-minute ad, titled "We Count! A Patriotic Musical Extravaganza," features the voice of "The Big Bang Theory's" Jim Parsons and Broadway star Barrett Doss. The spot will appear on Facebook targeting voters in the swing states of Arizona, Florida, Iowa, Michigan, North Carolina, Ohio, Pennsylvania and Wisconsin.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories